Komori
Daito Pharmaceutical (4577) · RiskRestated

Risk of Corporate Reorganization and Integration Among Business Partners

First written in FY2016. 2 of 3 entries say "Restated". Latest entry: FY2018.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20182016: 120162017: 120172018: 12018
Same theme, other companies
Risk of changes in customer and counterparty relationships arising from a business integrationA theme 3 companies write about · 3 as a headwind · 0 as a tailwind

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Corporate Reorganization and Integration Among Business Partners | Daito Pharmaceutical Co.,Ltd. (4577) | Komori